Medicare Enrolled
Dr. Jed Kaminetsky, MD
Urology Physician · New York, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kaminetsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaminetsky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kaminetsky
Dr. Jed Kaminetsky is an urology physician in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kaminetsky performed 42,030 Medicare services across 4,604 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kaminetsky received a total of $44,701 from 38 pharmaceutical and/or device companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kaminetsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in NY
$44,701 industry payments
Medicare Practice Summary
Medicare Utilization ↗42,030
Medicare services
Top 3% in NY for urology physician
4,604
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone undecanoate injection (Aveed) An injection of testosterone undecanoate, a form of testosterone hormone. This procedure involves administering the medication via injection. |
35,250 | $1 | $3 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,610 | $3 | $8 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,118 | $9 | $38 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
968 | $74 | $223 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
755 | $7 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
339 | $104 | $318 |
| PSA test (prostate cancer screening) | 279 | $18 | $55 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 212 | $137 | $508 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
145 | $218 | $732 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $49 | $142 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
133 | $18 | $55 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
128 | $8 | $24 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
115 | $398 | $528 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
107 | $87 | $247 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
95 | $89 | $274 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
72 | $11 | $175 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
69 | $123 | $344 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $123 | $392 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
62 | $13 | $30 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
51 | $57 | $150 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
41 | $8 | $26 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
37 | $25 | $77 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $30 | $78 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
31 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
31 | $8 | $24 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
24 | $222 | $444 |
| Injection, garamycin, gentamicin, up to 80 mg | 19 | $1 | $3 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
18 | $633 | $2,476 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
17 | $349 | $1,006 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
17 | $30 | $174 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
17 | $2,798 | $7,271 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
17 | $60 | $182 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
16 | $185 | $524 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$44,701
Total received (2018-2024)
Avg $6,386/year across 7 years
Top 7% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$34,326 (76.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,074 (18.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,302 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$634
2023
$409
2022
$5,654
2021
$6,679
2020
$2,207
2019
$17,259
2018
$11,860
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$149
Janssen Biotech, Inc.
$134
PROGENICS PHARMACEUTICALS, INC.
$126
Antares Pharma, Inc.
$57
BIOPROTECT MEDICAL, INC.
$45
Verity Pharmaceuticals Inc.
$37
Tolmar, Inc.
$24
PFIZER INC.
$21
Olympus America Inc.
$21
DENTSPLY IH AB
$20
Top 3 companies account for 64.5% of 2024 payments
All-time payments by company (2018-2024) ›
Antares Pharma, Inc.
$20,089
Olympus America Inc.
$10,647
Clarus Therapeutics Inc.
$4,007
Acerus Pharmaceuticals Corporation
$3,427
UroViu Corporation
$2,100
Olympus Corporation of the Americas
$1,350
Avadel Specialty Pharmaceuticals, LLC
$898
Astellas Pharma US Inc
$369
Blue Earth Diagnostics Limited
$299
Progenics Pharmaceuticals, Inc.
$284
Janssen Biotech, Inc.
$196
Dendreon Pharmaceuticals LLC
$149
PROGENICS PHARMACEUTICALS, INC.
$126
Janssen Products, LP
$100
DENTSPLY IH AB
$62
Supernus Pharmaceuticals, Inc.
$48
BIOPROTECT MEDICAL, INC.
$45
PFIZER INC.
$40
UroGen Pharma, Inc.
$40
Verity Pharmaceuticals Inc.
$37
Endo Pharmaceuticals Inc.
$34
NeoTract Inc.
$31
Aytu BioScience, Inc
$30
Myriad Genetic Laboratories, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$25
BOSTON SCIENTIFIC CORPORATION
$25
DENTSPLY IH Inc.
$25
Tolmar, Inc.
$24
Merck Sharp & Dohme Corporation
$22
MEDIVATION FIELD SOLUTIONS LLC
$21
TOLMAR Pharmaceuticals, Inc.
$18
Allergan, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Coloplast Corp
$17
ABBVIE INC.
$15
Metuchen Pharmaceuticals
$13
Rochester Medical Corporation
$13
Boston Scientific Corporation
$13
Top 3 companies account for 77.7% of all-time payments
Associated products mentioned in payments ›
Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · ELIGARD · ERLEADA · Erleada · JATENZO · JELMYTO · KEYTRUDA · LOFRIC · LoFric · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · OTREXUP · Olympus Resection Disposables · Otrexup · PROVENGE · PYLARIFY · Prolaris · REZUM · SPEEDICATH · Stendra · TLANDO · TOVIAZ · Tlando · Trelstar · Uro-G Flexible Cystoscope · UroLift · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (77%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for urology physician in NY.
Geographic Context
Urology physicians within 10 mi
722
Per 100K population
44.4
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kaminetsky is a mixed practice specialist, with above-average Medicare volume (top 3% in NY), with consulting-driven industry engagement in the top 7% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kaminetsky experienced with testosterone undecanoate injection (aveed)?
Based on Medicare claims data, Dr. Kaminetsky performed 35,250 testosterone undecanoate injection (aveed) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kaminetsky receive payments from pharmaceutical companies?
Yes. Dr. Kaminetsky received a total of $44,701 from 38 companies across 131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kaminetsky's costs compare to other urology physicians in New York?
Dr. Kaminetsky's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kaminetsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in New York
Browse urology physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Antares Pharma, Inc. Payments to Doctors
See all physicians who received payments from Antares Pharma, Inc.
By company
Olympus America Inc. Payments to Doctors
See all physicians who received payments from Olympus America Inc.
By company
Clarus Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Clarus Therapeutics Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology